A double-blind, placebo-controlled, randomized pilot study comparing quetiapine with placebo, associated to naltrexone, in the treatment of alcohol-dependent patients

Addictive Behaviors

Volumn 36, Issue 3, 2011, Pages 265-269

  Guardia, Josep ^a   Roncero, Carlos ^b   Galan, Jaime ^c   Gonzalvo, Begoña ^d   Burguete, Teresa ^a   Casas, Miquel ^b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c ASTRAZENECA   (United Kingdom)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Alcohol dependence; Antipsychotic; Combination; Craving; Naltrexone; Quetiapine

Indexed keywords

NALTREXONE; PLACEBO; QUETIAPINE;

ADULT; ALCOHOL ABSTINENCE; ALCOHOLISM; ANXIETY; ARTICLE; CONSTIPATION; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HUMAN; LIBIDO DISORDER; MALE; MENTAL STRESS; MONOTHERAPY; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SIDE EFFECT; SOMNOLENCE; STATISTICAL ANALYSIS; TREATMENT DURATION; XEROSTOMIA;

ADOLESCENT; ADULT; AGED; ALCOHOLISM; ANTIPSYCHOTIC AGENTS; DIBENZOTHIAZEPINES; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NALTREXONE; NARCOTIC ANTAGONISTS; OUTPATIENTS; PILOT PROJECTS; SINGLE-BLIND METHOD; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78650871465     PISSN: 03064603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addbeh.2010.11.006     Document Type: Article

References (35)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders 1994, American Psychiatric Association, Washington DC. Fourth Edition.
2. Anton R.F., Kranzler H., Breder C., Marcus R.N., Carson W.H., Han J. A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence. Journal of Clinical Psychopharmacology 2008, 28:5-12.
3. Anton R.F., Moak D.H., Latham P. The Obsessive Compulsive Drinking Scale: A self-rated instrument for the quantification of thoughts about alcohol and drinking behavior. Alcoholism: Clinical and Experimental Research 1995, 19:92-99.
4. Anton R.F., O'Malley S.S., Ciraulo D.A., Cisler R.A., Couper D., Donovan D.M., et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: The COMBINE study: A randomized controlled trial. Journal Of the American Medical Association 2006, 295:2003-2017.
5. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Archives of General Psychiatry 1961, 4:561-571.
6. Croissant B., Klein O., Gehrlein L., Kniest A., Hermann D., Diehl A., et al. Quetiapine in relapse prevention in alcoholics suffering from craving and affective symptoms: A case series. European Psychiatry 2006, 21:570-573.
7. Derogatis L.R. SCL-90-R. Administration, scoring and procedures manual I for the revised version of the SCL-90 1977, Johns Hopkins University Press, Baltimore.
8. Derogatis L. R. (2002). SCL-90-R. Cuestionario de 90 Sintomas. Manual. Adaptacion española de J.L. Gonzalez de Rivera y cols. Publicaciones de Psicologia Aplicada. Serie menor numero 297. TEA Ediciones S.A., Madrid.
9. Guardia J., Catafau A.M., Batlle F., Martín J.C., Segura L., Gonzalvo B., et al. Striatal dopaminergic D(2) receptor density measured by [(123)I]iodobenzamide SPECT in the prediction of treatment outcome of alcohol-dependent patients. American Journal of Psychiatry 2000, 157:127-129.
10. Guardia J., Segura L., Gonzalvo B., Iglesias L., Roncero C., Cardus M., et al. A double-blind, placebo-controlled study of olanzapine in the treatment of alcohol-dependence disorder. Alcoholism: Clinical Experimental Research 2004, 28:736-745.
11. Guy W. (1976). ECDEU assessment manual for psychopharmacology-Revised (DHEW Publ No ADM 76-338). Rockville, MD, U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs, pp 218-222.
12. Hutchison K.E., Ray L., Sandman E., Rutter M.C., Peters A., Davidson D., et al. The effect of olanzapine on craving and alcohol consumption. Neuropsychopharmacology 2006, 31:1310-1317.
13. Johnson B.A., Chen Y.R., Schmitz J., Bordnick P., Shafer A. Cue reactivity in cocaine-dependent subjects: Effects of cue type and cue modality. Addictive Behaviors 1998, 23:7-15.
14. Kampman K.M., Pettinati H.M., Lynch K.G., Whittingham T., Macfadden W., Dackis C., et al. A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism. Journal of Clinical Psychopharmacology 2007, 2:344-351.
15. Kiefer F., Jahn H., Tarnaske T., Helwig H., Briken P., Holzbach R., et al. Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: A double-blind, placebo-controlled study. Archives of General Psychiatry 2003, 60:92-99.
16. Kiefer F., Wiedemann K. Combined therapy: What does acamprosate and naltrexone combination tells us?. Alcohol and Alcoholism 2004, 39:542-547.
17. Kranzler H.R. Pharmacotherapy of alcoholism: Gaps in knowledge and opportunities for research. Alcohol and Alcoholism 2000, 35:537-547.
18. Lingjaerde O., Ahlfors U.G., Bech P., Dencker S.J., Elgen K. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatrica Scandinavica 1987, 334:1-100. Suppl.
19. Longoria J., Brown E.S., Perantie D.C., Bobadilla L., Nejtek V.A. Quetiapine for alcohol use and craving in bipolar disorder. Journal of Clinical Psychopharmacology 2004, 24:101-102.
20. Marra D., Warot D., Berlin I., Hispard E., Notides C., Tilikete S., et al. Amisulpride does not prevent relapse in primary alcohol dependence: Results of a pilot randomized, placebo-controlled trial. Alcoholism: Clinical and Experimental Research 2002, 26:1545-1552.
21. Martinotti G., Di Nicola M., Di Giannantonio M., Janiri L. Aripiprazole in the treatment of patients with alcohol dependence: A double-blind, comparison trial vs. Naltrexone. Journal of Psychopharmacology 2009, 23:123-129.
22. Modell J.G., Mountz J.M., Glaser F.B., Lee J.Y. Effect of haloperidol on measures of craving and impaired control in alcoholic subjects. Alcoholism: Clinical and Experimental Research 1993, 17:234-240.
23. Monnelly E.P., Ciraulo D.A., Knapp C., LoCastro J., Sepulveda I. Quetiapine for treatment of alcohol dependence. Journal of Clinical Psychopharmacology 2004, 24:532-535.
24. Preston K.L., Jasinski D.R. Abuse liability studies of opioid agonist-antagonists in humans. Drug and Alcohol Dependence 1991, 28:49-82.
25. Rubio G., Lopez M. Validacion del Cuestionario sobre los componentes obsesivo-compulsivo de bebida en alcoholicos españoles. Adicciones 1999, 11:7-16.
26. Seroquel [package insert]. Wilmington, Del: AstraZeneca Pharmaceuticals LP; 2007. Available at: Accessed September 14, 2007. http://www.astrazeneca-us.com/pi/seroquel.pdf.
27. Shaw G.K., Waller S., Majumdar S.K., Alberts J.L., Latham C.J., Dunn G. Tiapride in the prevention of relapse in recently detoxified alcoholics. British Journal of Psychiatry 1994, 165:515-523.
28. Spielberger C.D. State-trait anxiety inventory: A comprehensive bibliography 1984, Consultant Psychologists Press, Palo Alto, CA.
29. Spielberger C.D. State-trait anger expression-2. Professional manual 1999, Psychological Assessment Resources Inc.
30. Spielberger CD. (2001). STAXI-2. Inventario de Expresion de Ira Estado-Rasgo. Autores de la version española: JJ Miguel Tobal, MI Casado, A Cano Vindel, CD Spielberger. Publicaciones de Psicologia Aplicada. Serie menor numero 286. TEA Ediciones S.A., Madrid.
31. a edicion). Publicaciones de Psicologia Aplicada. Serie menor numero 124. TEA Ediciones S.A., Madrid.
32. Swift R. Emerging approaches to managing alcohol dependence. American Journal of Health-System Pharmacy 2007, 64(5 Suppl 3):S12-S22.
33. Volpicelli J.R., Alterman A.I., Hayashida M., O'Brien C.P. Naltrexone in the treatment of alcohol dependence. Archives of General Psychiatry 1992, 49:876-880.
34. Wiesbeck G.A., Weijers H.G., Lesch O.M., Glaser T., Toennes P.J., Boening J. Flupenthixol decanoate and relapse prevention in alcoholics: Results from a placebo-controlled study. Alcohol and Alcoholism 2001, 36:329-334.
35. Work Group on Substance Use Disorders, Kleber H.D., Weiss R.D., Anton R.F., Rounsaville B.J., George T.P., et al. Treatment of patients with substance use disorders. American Journal of Psychiatry 2006, 163(8 Suppl):5-82. Second Edition. American Psychiatric Association.